Biocon Limited (BOM:532523)
373.60
+1.20 (0.32%)
At close: Jul 11, 2025
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
9.35M INR
Profits / Employee
621.08K INR
Market Cap
499.34B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 16,315 | -230 | -1.39% |
Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
Mar 31, 2021 | 13,500 | 891 | 7.07% |
Mar 31, 2020 | 12,609 | 1,266 | 11.16% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 347,362 |
HDFC Bank | 214,521 |
Tata Consultancy Services | 607,979 |
Bharti Airtel | 28,673 |
ICICI Bank | 187,765 |
State Bank of India | 236,226 |
Infosys | 323,578 |
Hindustan Unilever | 18,802 |
Biocon News
- 5 days ago - Biocon to announce Q1 FY26 results on August 7 - Business Upturn
- 9 days ago - It’s wrong to blame Covid jabs for cardiac arrests: Biocon chief Kiran Mazumdar-Shaw - The Times of India
- 9 days ago - 'Caution Not Anti-Science': Siddaramaiah On Covid Vaccine-Sudden Death Claim - NDTV
- 10 days ago - Biocon Chief Counters Siddaramaiah's Covid Vaccine-Heart Attack Link Claim - NDTV
- 10 days ago - Biocon Biologics gets marketing authorisation from EC for Denosumab Biosimilars Vevzuo and Evfraxy - Business Upturn
- 11 days ago - India’s Biocon Aims to Lead Copycat Wegovy Sales in Canada From Next Year - Financial Post
- 16 days ago - Biocon subsidiary gets Health Canada nod for YESAFILI - Business Upturn
- 27 days ago - Biocon shares in focus as company reportedly plans to launch QIP to raise up to Rs 4,500 crore - Business Upturn